Navigation Links
Colorectal cancer screening in Canada is cost-effective
Date:7/12/2010

Colorectal cancer screening is cost-effective and offers the best value for provincial health ministries in Canada, states an article in CMAJ (Canadian Medical Association Journal) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj090845.pdf. A high sensitivity fecal test, such as the fecal immunochemical test, or colonoscopy every ten years is recommended.

Increased advanced detection helps prevent cancer and avoids future treatment costs.

The study, by researchers from the University of British Columbia and Dalhousie University, analyzed 10 screening strategies (including no screening) recommended in the American 2008 Multi-Society Task Force Guidelines on colorectal cancer screening.

"Depending on the strategy, screening yields reductions in colorectal cancer mortality between 39% and 83% and incidence between 26% and 81%," write Dr. Jennifer Telford and Dr. Robert Enns, University of British Columbia with coauthors.

These findings are consistent with previously published studies.

"Colorectal cancer screening of average-risk individuals is a cost-effective measure, even with less than perfect compliance," conclude the authors.


'/>"/>

Contact: Kim Barnhardt
kim.barnhardt@cmaj.ca
613-520-7116 x2224
Canadian Medical Association Journal
Source:Eurekalert

Page: 1

Related medicine news :

1. Could Hot Weather Affect Results of a Colorectal Cancer Test?
2. Smoking-related colorectal cancer in older women is associated with molecularly defined DNA changes
3. Smoking-related colorectal cancer in older women is associated with molecularly-defined DNA changes
4. Hydrophobic proteins: Potential biomarkers for colorectal cancer
5. Is it safe for endoscopic piecemeal mucosal resection in treating large sessile colorectal polyps?
6. Bacteria as a predicter of colorectal cancer
7. Exploring gender differences in colorectal cancer screenings
8. FDG-PET/CT plays a definite role in detecting colorectal cancer recurrences
9. Investigators examine colorectal cancer screening methods among diverse populations
10. Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention
11. Association of fiber and colorectal cancer risk differs depending on dietary assessment method
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... DevOps and Agile Software Development, has been awarded a contract by the Center ... Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies in ...
(Date:10/12/2017)... LA (PRWEB) , ... October 12, 2017 , ... Planet ... in the U.S., announced today its plans to open a flagship location in Covington, ... occupy the former Rooms To Go store next to Office Depot in the Holiday ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... been named one of Michigan’s 2017 Best and Brightest in Wellness® by Best ... in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
Breaking Medicine Technology: